JG
VNDA icon

Jain Global’s Vanda Pharmaceuticals VNDA Stock Holding History

Jain Global’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Buy
+25,200
New +$165K ﹤0.01% 1559
2026
Q1 		– Sell
-10,651
Closed -$93.9K – 1681
2025
Q4 		$93.9K Buy
+10,651
New +$58.6K ﹤0.01% 1114

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jain Global's VNDA Position: Q2 2026 in Review

Jain Global opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 25,200 shares worth $154K. The stake represents ﹤0.01% of the portfolio and ranks #1559 among its holdings. This is a return to the name: Jain Global previously reported a position in VNDA as recently as Q4 2025.

Jain Global first reported a position in VNDA in Q4 2025 and has held it in 2 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Jain Global held 25,200 shares of Vanda Pharmaceuticals worth $154K as of Q2 2026.
  • Vanda Pharmaceuticals was a new Jain Global position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1559 holding.
  • Jain Global first reported a position in Vanda Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.